ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

JANX Janux Therapeutics Inc

47.39
0.29 (0.62%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Janux Therapeutics Inc JANX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.29 0.62% 47.39 08:34:00
개장가 저가 고가 종가 전일 종가
47.08 46.51 48.23 47.39 47.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/03/202406:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/03/202406:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/03/202406:11EDGAR2Form 8-K - Current report
09/03/202406:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
01/03/202407:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/03/202407:11EDGAR2Form 8-K - Current report
29/02/202415:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
29/02/202411:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/02/202407:15EDGAR2Form 8-K - Current report
28/02/202411:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/202407:23EDGAR2Form 8-K - Current report
28/02/202407:00BWJanux Therapeutics Announces Proposed Public Offering of..
27/02/202406:05BWJanux Announces Encouraging Safety and Efficacy Data in..
20/02/202422:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
10/02/202406:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202406:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202423:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
04/01/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202306:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:07EDGAR2Form 8-K - Current report
08/11/202306:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
08/09/202307:14EDGAR2Form 144 - Report of proposed sale of securities
15/08/202305:33EDGAR2Form 144 - Report of proposed sale of securities
09/08/202305:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:17EDGAR2Form 8-K - Current report
09/08/202305:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
19/07/202306:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/07/202305:16EDGAR2Form 8-K - Current report
17/07/202321:45BWJanux Therapeutics Announces Pricing of $60 Million..
17/07/202321:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
17/07/202321:06EDGAR2Form 8-K - Current report
17/07/202321:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
06/06/202305:35BWJanux Therapeutics Appoints Zachariah McIver, D.O., Ph.D.,..
10/05/202305:01BWJanux Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock